High-Risk Medication Prescriptions in Primary Care for Women Without Documented Contraception

Journal of the American Board of Family Medicine: JABFM

article

Bethany D. Panchal¹  Rebecca Cash²  Camille Moreno³  Emily Vrontos¹  Cheryl Bourne¹  Sandra Palmer¹  Amy Simpson¹  Ashish R. Panchal² 

[1] From Department of Family Medicine, The Ohio State University College of Medicine;Division of Epidemiology, The Ohio State University College of Public Health;Department of OB/GYN and Specialized Women’s Health, Cleveland Clinic Foundation;Department of Emergency Medicine, The Ohio State University College of Medicine

关键词: Child Health;    Community Medicine;    Contraception;    Counseling;    Infant Health;    Lisinopril;    Logistic Models;    Ondansetron;    Pharmacoepidemiology;    Primary Health Care;    Preconception Care;    Pregnancy;    Prenatal Care;    Reproductive Health;    Teratogens;   

DOI  :  10.3122/jabfm.2019.04.180281

学科分类：过敏症与临床免疫学

来源: The American Board of Family Medicine

【 摘 要 】

Introduction: During pregnancy, women may be exposed to teratogenic medications resulting in a risk of complications and poor maternal-fetal outcomes. The objective of this study was to evaluate the prescription of teratogenic medications in women of childbearing age and the associated prescription of contraception in the primary care setting.

【 授权许可】

CC BY